Congo’s outbreak is accelerating—and the tools arriving may still be chasing it. If you’re joining us mid-arc, here’s the short version: Congo’s Bundibugyo outbreak had already pushed authorities into river-corridor prevention work and a six-province response. AP-reported Ministry of Health data stood at 5,514 recorded cases and 2,642 deaths. WHO’s Emergency Committee had also updated temporary recommendations covering surveillance, infection prevention, clinical care, risk communication, mass gatherings, and domestic mobility. This is Ebola Watch. Today: a case-count gap big enough to change the response, vaccines finally reaching workers, and why an Ebola-free Uganda is stocking treatment at the border. Anadolu Agency, with James Tasamba:
The death toll from the current Ebola virus outbreak, which began in the Democratic Republic of Congo in May, surpassed 2,800 on Sunday, according to the latest data released by the country's health authorities. The Health Ministry data showed that the number of confirmed cases had reached 5,945 across six provinces. At least 1,327 people have recovered, while 896 confirmed patients are currently in isolation or in hospital.
Here’s the DRC Bundibugyo update: health authorities now report 5,945 confirmed cases across six provinces and more than 2,800 deaths. Those numbers capture confirmed cases, not every infection in the community. Sixty health zones. That’s what changes the scale for me: this is no longer a crisis contained to one hard-hit pocket of the country. And 896 confirmed patients are in isolation or hospital, while 1,327 people have recovered. Care is reaching people, but that doesn’t soften WHO’s warning about sustained transmission and rapid viral evolution. Dr. Richard Kitenge puts it bluntly: there’s no magic fix. If families fear reporting illness or can’t work with response teams, 7,500 more tracers or another pledge on paper won’t catch infections early enough. From The Bold News:
The Congo began vaccinating against Ebola on Thursday as the health authorities worked to reduce the outbreak, which is the fastest growing in recorded history. Priority is being given to frontline health workers who are involved in Ebola response. The Ervebo vaccination was successful in previous Ebola outbreaks that were caused by another, more common strain.
The rollout date we needed is here: Ervebo went into frontline health workers’ arms Thursday in Kisangani. Good. But with nearly 6,000 confirmed cases, it’s a late start against a very fast-moving outbreak. But we need to label this carefully. Ervebo worked in prior outbreaks caused by the Zaire strain; this outbreak is Bundibugyo, and there’s no licensed vaccine for it. The initial doses protect people facing exposure every day while the 20,000-dose trial tests whether it protects against this strain. Fifty thousand doses earmarked for health workers and frontline staff is meaningful—unless the vaccine has limited effect on Bundibugyo. It may be vital, but we don’t yet know how well it works against this strain. I think it’s a defensible bet. Health Minister Roger Kamba says the first priority is the response workforce, and protecting clinicians helps preserve diagnosis, isolation, and care. Against the death toll we just discussed, getting doses from approval into clinics is real progress, even if it tells us nothing yet about strain-specific efficacy. ABS Africa TV, with Jason Gale, Melos Ambaye and Janice Kew:
The Ebola epidemic sweeping the Democratic Republic of Congo may be three times larger than official figures indicate, Africa’s top public-health agency said, suggesting thousands of infections are going undetected as authorities struggle to track transmission. Congo has officially recorded 5,713 confirmed infections and 2,744 deaths through Aug. 25. An outbreak three times that size would imply about 17,100 infections.
Africa CDC says the outbreak may be three times the official size. Put that next to the 5,945 confirmed cases you just heard: we could be looking at roughly 17,000 infections, with thousands of people never entering the count at all. Careful with the labels: 5,945 is the ministry’s confirmed total as of August 30. The roughly 17,100 figure is Africa CDC’s epidemiological estimate, extrapolated from its August 25 baseline. It should be treated as an estimate, not another confirmed tally. And if the working number is that far off, every plan built around reported cases gets shakier—contact tracing, treatment beds, supplies, all of it. You can’t catch chains of transmission you haven’t found. There’s one narrow encouraging signal in Africa CDC’s update: community deaths fell in areas where health workers were deployed, from about 63 percent over two weeks to roughly half in the latest several days. That’s a move in the right direction, but it covers days—not proof the outbreak is contained. This one's from Médecins Sans Frontières (MSF):
In response to the spread of the 17th Ebola disease outbreak in the Democratic Republic of the Congo (DRC), Médecins Sans Frontières (MSF) is strengthening its response in North Kivu. In cooperation with the Ministry of Health, the organisation has opened a new Ebola Treatment Centre (ETC) in Beni.
MSF opened an Ebola Treatment Centre in Beni on August 28 alongside the Health Ministry. Its August 22 snapshot put North Kivu at 714 confirmed cases and 490 confirmed deaths. The new center adds capacity in a province carrying a severe share of the outbreak. And Beni is the same place where a Red Cross ambulance was destroyed nine days earlier. The treatment center is progress. The brutal part is keeping patients, staff, and ambulances able to reach it. Exactly. Early diagnosis and treatment can improve survival and reduce spread inside households, MSF says. But a building only helps if people can safely get to it, and Ebola care can’t crowd out routine health services. We just heard vaccines reaching health workers in Kisangani, and Beni now has additional treatment capacity. Both are real tools on the ground against what MSF calls the fastest-spreading Ebola outbreak ever recorded globally. The Independent (Uganda), with RONALD MUSOKE:
The United States has delivered an experimental antibody treatment for Ebola to Uganda as the country strengthens its preparedness against another possible cross-border spread of the disease from the Democratic Republic of Congo (DRC). The treatment, known as MBP134, was handed over to Uganda’s Ministry of Health on Aug.27, with the U.S. government saying the vials are available for immediate use should a new Ebola case be detected.
Uganda was declared Ebola-free on August 27—and that same day, it took delivery of experimental MBP134 for immediate use. For travelers, that shows how seriously Kampala is taking the DRC border. At Kajjansi outside Kampala, those vials are already pre-positioned before a case appears. MBP134 is an experimental antibody treatment, not a vaccine, and Uganda has zero active cases; this is preparedness, not evidence of transmission inside Uganda. But it’s a pretty blunt preparedness signal. After the nearly 6,000 confirmed DRC cases we just covered, Uganda is treating cross-border movement as an immediate risk. For ordinary visitors, Ebola still requires direct contact with infected bodily fluids; it does not spread through casual shared air. The practical concern is for border health systems and communities with regular cross-border contact—and having treatment already in-country can save crucial time. Need a daily briefing on your own industry? Lantern makes private versions like this one—covering your competitors, market, or beat, delivered to a private feed for the whole team. Learn more at lantern podcasts dot com slash briefings, with a 14-day free trial.
Links to every story are in the show notes, so you can dig into whichever developments caught your attention. Thanks for listening, and we’ll be back with more tomorrow. That’s today’s Ebola Watch. This is a Lantern Podcast.